Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Valvular Heart Disease

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 283 articles: HTML format

Single Articles

November 2026
1. MILOJEVIC M, Heuts S, Sadaba R, Myers PO, et al
   Transcatheter aortic valve implantation vs surgical replacement in low-risk aortic stenosis: time-dependent late mortality in a pooled analysis of trials.
   Eur Heart J. 2026 Nov 4:ehag877. doi: 10.1093.
   PubMed    
   
   
   October 2026
2. LIU H, Zhou R, Hua Z
   A decade-long device-valve interaction: severe aortic regurgitation after residual ventricular septal defect closure.
   Eur Heart J. 2026 Oct 24:ehag862. doi: 10.1093.
   PubMed    
   
   
   
3. PEDICINO D, Vergallo R
   Weekly Journal Scan: from TRICk to treat-the first evidence of a clinical outcome benefit with transcatheter tricuspid valve intervention.
   Eur Heart J. 2026 Oct 5:ehag780. doi: 10.1093.
   PubMed    
   
   
   September 2026
4. TONA F
   What does fractional flow reserve measure after transcatheter aortic valve implantation?
   Eur Heart J. 2026 Sep 29:ehag777. doi: 10.1093.
   PubMed    
   
   
   August 2026
5. BAGNALL TJ, Wright D, Hildick-Smith D
   Occlusive transcatheter aortic valve thrombosis despite oral anticoagulation.
   Eur Heart J. 2026 Aug 31:ehag668. doi: 10.1093.
   PubMed    
   
   
   
6. DONATI TG, Agbariah A, Benz DC, Hebeisen M, et al
   Tricuspid regurgitation and outcomes in arrhythmogenic right ventricular cardiomyopathy: role of tricuspid annulus dilatation.
   Eur Heart J. 2026 Aug 30:ehag694. doi: 10.1093.
   PubMed    
   
   
   
7. MARTINI M, Bauce B
   Tricuspid regurgitation in arrhythmogenic right ventricular cardiomyopathy: marker, mediator, or both?
   Eur Heart J. 2026 Aug 30:ehag635. doi: 10.1093.
   PubMed    
   
   
   
8. KIM HJ, Yoo BA, Koo HJ, Kim HR, et al
   Surgical aortic valve replacement in patients with moderately dilated aorta: long-term risk of aortic events.
   Eur Heart J. 2026 Aug 20:ehag658. doi: 10.1093.
   PubMed    
   
   
   
9. PU J
   Ferroptosis in calcific aortic valve disease: linking intraleaflet haemorrhage to valve calcification.
   Eur Heart J. 2026 Aug 18:ehag599. doi: 10.1093.
   PubMed    
   
   
   
10. CREA F
    Transcatheter aortic valve implantation vs surgical aortic valve replacement for aortic stenosis: the saga continues.
    Eur Heart J. 2026;47:3997-4002.
    PubMed    
    
    
    
11. 
    Correction to: 2025 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoraci
    Eur Heart J. 2026 Aug 6:ehag625. doi: 10.1093.
    PubMed    
    
    
    
12. KAGIYAMA N, Kaneko T, Hayashida K
    Defining the boundaries of atrial functional mitral regurgitation: evidence from real-world data.
    Eur Heart J. 2026 Aug 5:ehaf930. doi: 10.1093.
    PubMed    
    
    
    
13. VON STEIN P, Zoghbi WA, Mauri V
    Challenges in defining atrial secondary mitral regurgitation.
    Eur Heart J. 2026 Aug 5:ehaf929. doi: 10.1093.
    PubMed    
    
    
    
14. DIB N, Poirier N, Kamp A, Seslar SP, et al
    Tetralogy of Fallot: electrophysiology-guided surgical ablation during pulmonary valve replacement.
    Eur Heart J. 2026;47:3965-3976.
    PubMed     Abstract available
    
    
    June 2026
15. TOWER-RADER A, Masri A, Nassif ME, Abraham TP, et al
    Aficamten in symptomatic obstructive hypertrophic cardiomyopathy: the FOREST-HCM long-term study.
    Eur Heart J. 2026;47:3120-3131.
    PubMed     Abstract available
    
    
    
16. SENGUPTA PP, Yanamala N, Pibarot P
    Diastolic dysfunction is linked to the initiation and progression of aortic stenosis: a hypothesis.
    Eur Heart J. 2026 Jun 23:ehag435. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. YAN W, Deng W, Song L
    Chronic Escherichia coli myocardial abscess without infective endocarditis associated dysfunction of mitral valve.
    Eur Heart J. 2026 Jun 23:ehag492. doi: 10.1093.
    PubMed    
    
    
    
18. DOENST T, Prendergast B, Allen CJ, Barili F, et al
    Great debate: surgical aortic valve replacement is first choice for aortic stenosis in patients with a life expectancy beyond 5 years.
    Eur Heart J. 2026 Jun 15:ehag262. doi: 10.1093.
    PubMed     Abstract available
    
    
    
19. DAYAN V, Kaul S, Shah BN
    Transcatheter vs surgical aortic valve implantation: age vs lifetime perspective.
    Eur Heart J. 2026 Jun 15:ehag407. doi: 10.1093.
    PubMed    
    
    
    
20. LOPEZ-ALFEREZ R, Uribe-Pena MJ
    Near 49-year function of a Braunwald-Cutter mitral valve prosthesis.
    Eur Heart J. 2026 Jun 11:ehag458. doi: 10.1093.
    PubMed    
    
    
    
21. AKHTAR M, Naseer B, Sajid I
    Unresolved long-term risks and generalizability limitations: transcatheter vs aortic valve replacement from the RHEAI trial.
    Eur Heart J. 2026 Jun 5:ehag204. doi: 10.1093.
    PubMed    
    
    
    
22. QIN Z, Haftbaradaran Esfahani P, Pawelzik SC, Shu S, et al
    Ferroptosis promotes aortic stenosis through 5-lipoxygenase.
    Eur Heart J. 2026 Jun 2:ehag397. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2026
23. AARTS HM, Delewi R, Voskuil M
    Routine FFR-guided revascularization in patients undergoing transcatheter aortic valve implantation, one step too far?
    Eur Heart J. 2026 May 22:ehag256. doi: 10.1093.
    PubMed    
    
    
    
24. BUTLER J, Khan MS, Friede T, Placzek M, et al
    Mitral transcatheter edge-to-edge repair and outcomes according to baseline health status: the RESHAPE-HF2 trial.
    Eur Heart J. 2026;47:2290-2304.
    PubMed     Abstract available
    
    
    
25. OKUNO T, Tanaka T, Kuwata S
    Moderate mitral regurgitation in severe tricuspid regurgitation: innocent bystander or actionable target?
    Eur Heart J. 2026 May 8:ehag276. doi: 10.1093.
    PubMed    
    
    
    April 2026
26. KASSAR M, Praz F, Gercek M, Fortmeier V, et al
    Combined transcatheter mitral and tricuspid edge-to-edge repair or tricuspid edge-to-edge repair alone in moderate mitral regurgitation: a propensity-matched analysis.
    Eur Heart J. 2026 Apr 24:ehag186. doi: 10.1093.
    PubMed     Abstract available
    
    
    
27. LODIN K, Oliveira Da Silva C, Shahim B
    Mitral annular disjunction and ventricular arrhythmias after mitral valve surgery: true, longer, inferolateral disjunctions matter.
    Eur Heart J. 2026 Apr 7:ehag243. doi: 10.1093.
    PubMed    
    
    
    March 2026
28. DREYFUS J, Praz F, Hahn R, Margonato D, et al
    Tricuspid regurgitation: standardized stepwise work-up from referral to expert heart valve centre.
    Eur Heart J. 2026 Mar 28:ehag214. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. BORGER MA, Praz F
    The 'ten commandments' for the 2025 ESC/EACTS guidelines for the management of valvular heart disease.
    Eur Heart J. 2026 Mar 24:ehag096. doi: 10.1093.
    PubMed    
    
    
    
30. QIAN X, Xu L, Zheng Y, Fan Z, et al
    Senescence-associated metabolic alterations aggravate calcific aortic valve disease.
    Eur Heart J. 2026 Mar 17:ehag191. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. VAN DER ZANDE JA, Ramlakhan KP, Sliwa K, Gnanaraj JP, et al
    Pregnancy with a prosthetic heart valve, thrombosis, and bleeding: the ESC EORP Registry of Pregnancy and Cardiac disease III.
    Eur Heart J. 2026;47:1318-1335.
    PubMed     Abstract available
    
    
    
32. LI Q, Fu Z, Song G
    Wearable acoustic cardiography: a novel non-invasive digital sentinel for subclinical leaflet thrombosis after transcatheter aortic valve replacement.
    Eur Heart J. 2026 Mar 13:ehag156. doi: 10.1093.
    PubMed    
    
    
    
33. PETRONIO AS, Delgado V, Praz F
    The ESC Council on Valvular Heart Disease today and the vision for tomorrow.
    Eur Heart J. 2026 Mar 13:ehag094. doi: 10.1093.
    PubMed    
    
    
    
34. CREA F
    Valvular heart disease: challenges and opportunity.
    Eur Heart J. 2026;47:1271-1275.
    PubMed    
    
    
    
35. 
    Correction to: Transcatheter edge-to-edge repair vs medical therapy in atrial functional mitral regurgitation: a propensity score-based comparison from the OCEAN-Mitral and REVEAL-AFMR registries.
    Eur Heart J. 2026 Mar 11:ehag190. doi: 10.1093.
    PubMed    
    
    
    
36. CICEK S, Durdu MS
    Prosthesis durability and anatomy in transcatheter aortic valve implantation decision-making.
    Eur Heart J. 2026 Mar 5:ehag133. doi: 10.1093.
    PubMed    
    
    
    February 2026
37. ZAMPIERI M, Saberi S, D'Ascenzi F, Papadakis M, et al
    Hypertrophic cardiomyopathy: changing the paradigm of exercise prescription and competitive sport participation.
    Eur Heart J. 2026;47:902-915.
    PubMed     Abstract available
    
    
    
38. RAZAVI AC, Bhatia HS, Marrero N, Dzaye O, et al
    Aspirin use, lipoprotein(a), and calcific aortic valve disease: the Multi-ethnic Study of Atherosclerosis.
    Eur Heart J. 2026 Feb 21:ehag018. doi: 10.1093.
    PubMed     Abstract available
    
    
    
39. FAZA NN, Delgado V, Berrebi A, Zoghbi WA, et al
    Three-dimensional echocardiography for valvular heart disease: clinical implications.
    Eur Heart J. 2026 Feb 21:ehaf1127. doi: 10.1093/eurheartj/ehaf1127.
    PubMed     Abstract available
    
    
    
40. MAZNYCZKA A, Pilgrim T, Philippon F, Rodes-Cabau J, et al
    Conduction disturbances after transcatheter aortic valve implantation.
    Eur Heart J. 2026 Feb 19:ehag093. doi: 10.1093.
    PubMed     Abstract available
    
    
    
41. LE RUZ R, Brener M, Rommel KP
    Acute haemodynamic instability after transcatheter tricuspid valve replacement: insights from pressure-volume loops.
    Eur Heart J. 2026 Feb 18:ehag031. doi: 10.1093.
    PubMed    
    
    
    
42. MARSAN NA, Bax JJ
    Transcatheter tricuspid valve replacement: defining the sweet spot for intervention.
    Eur Heart J. 2026 Feb 18:ehaf954. doi: 10.1093.
    PubMed    
    
    
    
43. SABATINO J, De Rosa S, Torella D
    Subvalvular aortic stenosis in adulthood: stable, manageable, but never simple.
    Eur Heart J. 2026 Feb 9:ehaf1089. doi: 10.1093/eurheartj/ehaf1089.
    PubMed    
    
    
    
44. DE KEIJZER AR, Meccanici F, Keuning ZA, Esser FAJ, et al
    Subvalvular aortic stenosis in adults: clinical course and long-term outcomes.
    Eur Heart J. 2026 Feb 4:ehaf1078. doi: 10.1093/eurheartj/ehaf1078.
    PubMed     Abstract available
    
    
    January 2026
45. AMAT-SANTOS IJ, Real C, Galan-Arriola C, Diz-Diaz J, et al
    Transcatheter aortic valve-in-mechanical valve replacement: a first-in-human study.
    Eur Heart J. 2026 Jan 30:ehag019. doi: 10.1093.
    PubMed    
    
    
    
46. BAUMGARTNER H, Iung B, Messika-Zeitoun D
    Mitral transcatheter edge-to-edge repair for ventricular secondary mitral regurgitation: do we have enough evidence for its benefit?
    Eur Heart J. 2026 Jan 29:ehaf1076. doi: 10.1093/eurheartj/ehaf1076.
    PubMed    
    
    
    
47. BAUMGARTNER H, Iung B, Messika-Zeitoun D
    The year in cardiovascular medicine 2025: the top 10 papers in valvular heart disease.
    Eur Heart J. 2026 Jan 23:ehaf1088. doi: 10.1093/eurheartj/ehaf1088.
    PubMed    
    
    
    
48. DOCHERTY KF, Otto CM, McMurray JJV
    Valvular heart failure: evolving pharmacological approaches.
    Eur Heart J. 2026 Jan 13:ehaf1079. doi: 10.1093/eurheartj/ehaf1079.
    PubMed     Abstract available
    
    
    December 2025
49. KERN MJ, Seto AH
    Fractional flow reserve-guided percutaneous coronary intervention for transcatheter aortic valve implantation: a FAITAVI accompli for better outcomes?
    Eur Heart J. 2025 Dec 23:ehaf973. doi: 10.1093.
    PubMed    
    
    
    
50. YU H, Yang K, Lu M
    Mitral valve blood cyst mimicking left ventricular outflow tract obstruction: a multi-imaging perspective.
    Eur Heart J. 2025 Dec 23:ehaf1026. doi: 10.1093/eurheartj/ehaf1026.
    PubMed    
    
    
    
51. RIBICHINI FL, Scarsini R, Pesarini G, Fabris T, et al
    Physiology vs angiography-guided percutaneous coronary intervention in transcatheter aortic valve implantation: the FAITAVI trial.
    Eur Heart J. 2025 Dec 19:ehaf974. doi: 10.1093.
    PubMed     Abstract available
    
    
    
52. ARAMOUNI K, Dhore A, Chamsi-Pasha M
    Loeffler's endocarditis and mitral regurgitation: look below the valve.
    Eur Heart J. 2025 Dec 12:ehaf996. doi: 10.1093.
    PubMed    
    
    
    November 2025
53. CAO J, Shen F, Lu F
    Tricuspid valve replacement with a LuX-Valve for tricuspid stenosis via a right atrium access.
    Eur Heart J. 2025 Nov 28:ehaf972. doi: 10.1093.
    PubMed    
    
    
    
54. ZHOU Y, Shang X, Zhong Y
    One-stop percutaneous intervention for severe aortic regurgitation and perivalvular abscess perforation caused by destructive infective endocarditis after David procedure.
    Eur Heart J. 2025 Nov 28:ehaf971. doi: 10.1093.
    PubMed    
    
    
    
55. CHEN X, Jilaihawi H, Wang Y
    One-stop pulmonary artery denervation and transcatheter tricuspid annuloplasty in combined pre- and post-capillary pulmonary hypertension with severe tricuspid regurgitation.
    Eur Heart J. 2025 Nov 28:ehaf934. doi: 10.1093.
    PubMed    
    
    
    
56. CHO SH, Won KY, Kim DH
    AA amyloidosis with clinically overt cardiac involvement confirmed by amyloid A deposition in aortic valve fibroelastoma.
    Eur Heart J. 2025 Nov 28:ehaf894. doi: 10.1093.
    PubMed    
    
    
    
57. CREA F
    Hot topics in valvular heart disease and dyslipedaemias.
    Eur Heart J. 2025;46:4623-4627.
    PubMed    
    
    
    
58. YOGESWARAN V, Otto CM
    Clinical management of moderate mixed aortic valve disease.
    Eur Heart J. 2025 Nov 5:ehaf790. doi: 10.1093.
    PubMed    
    
    
    October 2025
59. MARON MS, Gimeno JR, Veselka J, Barriales-Villa R, et al
    Efficacy of aficamten in patients with obstructive hypertrophic cardiomyopathy and mild symptoms: results from the SEQUOIA-HCM trial.
    Eur Heart J. 2025;46:4076-4086.
    PubMed     Abstract available
    
    
    
60. BAKA T, Moore J, Qin F, Yurista SR, et al
    Empagliflozin enhances metabolic efficiency and improves left ventricular hypertrophy in a hypertrophic cardiomyopathy mouse model.
    Eur Heart J. 2025;46:4105-4119.
    PubMed     Abstract available
    
    
    
61. LONG Y, Zhou D, Pan W
    Killing three birds with one stone: transcatheter salvage of aorto-atrial fistula and paravalvular leaks following transcatheter tricuspid valve replacement.
    Eur Heart J. 2025 Oct 17:ehaf796. doi: 10.1093.
    PubMed    
    
    
    
62. LOPEZ SANTI P, Bernard J, Chua A, Laenens D, et al
    Outcomes of moderate mixed aortic valve stenosis and regurgitation.
    Eur Heart J. 2025 Oct 17:ehaf791. doi: 10.1093.
    PubMed     Abstract available
    
    
    
63. MCDONAUGH B, Redwood S, Patterson T
    Transcatheter edge-to-edge repair for atrial functional mitral regurgitation: the final frontier.
    Eur Heart J. 2025 Oct 17:ehaf792. doi: 10.1093.
    PubMed    
    
    
    
64. WANG Y, Jin J, Yu S
    Transcatheter aortic valve replacement in unicuspid aortic stenosis: revealed by multimodal imaging.
    Eur Heart J. 2025 Oct 15:ehaf817. doi: 10.1093.
    PubMed    
    
    
    
65. ORR C, Praz F, Kirk BH
    Enhanced education to improve aortic stenosis patient pathways: the AortiCare programme.
    Eur Heart J. 2025 Oct 15:ehaf622. doi: 10.1093.
    PubMed    
    
    
    
66. GORI T, Treede H
    Equal tools, unequal tolls: should sex influence decision-making for aortic valve stenosis?
    Eur Heart J. 2025 Oct 9:ehaf762. doi: 10.1093.
    PubMed    
    
    
    
67. GARCIA-PAVIA P, Gonzalez-Lopez E, Anderson LJ, Cappelli F, et al
    Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC Heart Failure Association.
    Eur Heart J. 2025 Oct 7:ehaf710. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2025
68. ARMOUNDAS AA
    The electrocardiogram reimagined: AI-ECG as a prognostic beacon for valvular heart disease.
    Eur Heart J. 2025 Sep 5:ehaf584. doi: 10.1093.
    PubMed    
    
    
    
69. CUDDY SAM
    Aortic stenosis: need for treatment of co-existent cardiac amyloidosis?
    Eur Heart J. 2025 Sep 5:ehaf558. doi: 10.1093.
    PubMed    
    
    
    
70. BLEIZIFFER S, Leuschner F, Rudolph TK, Vonthein R, et al
    Sex-specific outcomes after transcatheter or surgical treatment of aortic valve stenosis: the DEDICATE-DZHK6 trial.
    Eur Heart J. 2025 Sep 3:ehaf519. doi: 10.1093.
    PubMed     Abstract available
    
    
    
71. YUAN X, Ju F, Wu H, Zhao Y, et al
    Surgical left atrial appendage occlusion in valvular heart disease without atrial fibrillation: the OPINION trial.
    Eur Heart J. 2025 Sep 1:ehaf674. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2025
72. LURZ P, Hahn RT, Kodali S, Makkar R, et al
    Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial.
    Eur Heart J. 2025 Aug 29:ehaf676. doi: 10.1093.
    PubMed     Abstract available
    
    
    
73. PRAZ F, Borger MA, Lanz J, Marin-Cuartas M, et al
    2025 ESC/EACTS Guidelines for the management of valvular heart disease.
    Eur Heart J. 2025 Aug 29:ehaf194. doi: 10.1093.
    PubMed    
    
    
    
74. HEERINGA TJP, Hegeman RMJJ, Koop Y, El Mathari S, et al
    Surgical myectomy for hypertrophic cardiomyopathy: procedural volume and outcomes.
    Eur Heart J. 2025 Aug 29:ehaf560. doi: 10.1093.
    PubMed     Abstract available
    
    
    
75. MAURIZI N, Monda E, Biagini E, Field E, et al
    Hypertrophic cardiomyopathy: prevalence of disease-specific red flags.
    Eur Heart J. 2025;46:3082-3094.
    PubMed     Abstract available
    
    
    
76. BUTERA G, Montanaro C, Maisano F
    Multiple clips for transcatheter mitral valve repair in failing Fontan.
    Eur Heart J. 2025 Aug 12:ehaf469. doi: 10.1093.
    PubMed    
    
    
    
77. ADAMO M, Pagnesi M, Ajmone Marsan N, Bauersachs J, et al
    Heart failure with reduced ejection fraction and ventricular secondary mitral regurgitation: a holistic approach.
    Eur Heart J. 2025 Aug 1:ehaf480. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2025
78. WATANABE A, Hiruma Y, Asanuma T
    Immortal time bias for active treatment of cardiac transthyretin amyloidosis with aortic stenosis.
    Eur Heart J. 2025 Jul 30:ehaf539. doi: 10.1093.
    PubMed    
    
    
    
79. NITSCHE C, Ristl R, Treibel TA
    Avoiding immortal time bias for cardiac transthyretin treatment in aortic stenosis.
    Eur Heart J. 2025 Jul 30:ehaf542. doi: 10.1093.
    PubMed    
    
    
    
80. LI Y, Wei L, Zhang C
    Breakthrough outflow tract unlocking: modified transapical balloon-assisted transseptal mitral annuloplasty for high-risk mitral valve-in-ring patients.
    Eur Heart J. 2025 Jul 25:ehaf536. doi: 10.1093.
    PubMed    
    
    
    
81. CREA F
    Challenges in antithrombotic treatment and in the management of valvular heart disease.
    Eur Heart J. 2025;46:2717-2721.
    PubMed    
    
    
    
82. LIANG Y, Sau A, Zeidaabadi B, Barker J, et al
    Artificial intelligence-enhanced electrocardiography to predict regurgitant valvular heart diseases: an international study.
    Eur Heart J. 2025 Jul 16:ehaf448. doi: 10.1093.
    PubMed     Abstract available
    
    
    
83. ALHAKAK A, Butt JH, Havers-Borgersen E, Ostergaard L, et al
    Mitral valve replacement or repair and long-term risk of infective endocarditis: a Danish nationwide study.
    Eur Heart J. 2025 Jul 11:ehaf342. doi: 10.1093.
    PubMed     Abstract available
    
    
    
84. GIACOPPO D
    Unveiling the risk of infective endocarditis after mitral valve replacement and mitral valve repair.
    Eur Heart J. 2025 Jul 11:ehaf099. doi: 10.1093.
    PubMed    
    
    
    
85. KANEKO T, Kagiyama N, Okazaki S, Amano M, et al
    Transcatheter edge-to-edge repair vs medical therapy in atrial functional mitral regurgitation: a propensity score-based comparison from the OCEAN-Mitral and REVEAL-AFMR registries.
    Eur Heart J. 2025 Jul 9:ehaf511. doi: 10.1093.
    PubMed     Abstract available
    
    
    
86. LIU H, Fang Y, Cheng W
    Traumatic interventricular septal dissection in a bicuspid aortic valve patient: a rare extension into the left ventricle.
    Eur Heart J. 2025 Jul 4:ehaf499. doi: 10.1093.
    PubMed    
    
    
    
87. BLITZER D, Meinrenken CJ, Apelgren NB, Chavez XS, et al
    Carbon emission analysis of aortic valve replacement: the environmental footprint of transcatheter vs. surgical procedures.
    Eur Heart J. 2025 Jul 2:ehaf379. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2025
88. KARTHIKEYAN G, Rajashekar P, Devasenapathy N, Biswas S, et al
    Urgent surgery vs fibrinolytic therapy for left-sided prosthetic valve thrombosis: a randomized trial.
    Eur Heart J. 2025 Jun 27:ehaf391. doi: 10.1093.
    PubMed     Abstract available
    
    
    
89. YANG WL, Hu BY
    Giant ascending aortic aneurysm in a 6-year-old boy with LOX gene mutation associated with familial thoracic aortic aneurysm type 10.
    Eur Heart J. 2025 Jun 24:ehaf402. doi: 10.1093.
    PubMed    
    
    
    
90. CREA F
    Focus on juvenile hypertension, deep learning-qualified body composition for risk stratification, infective endocarditis, and mixed valvular heart disease.
    Eur Heart J. 2025;46:2249-2252.
    PubMed    
    
    
    
91. COMPAGNONE M, Windecker S, Dall'Ara G, Galvani M, et al
    Great debate: Transcatheter aortic valve implantation should also be performed in non-surgical centres.
    Eur Heart J. 2025 Jun 5:ehaf363. doi: 10.1093.
    PubMed    
    
    
    
92. NITSCHE C, Dobner S, Rosenblum HR, Patel KP, et al
    Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosis.
    Eur Heart J. 2025 Jun 2:ehaf362. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2025
93. BASU J, Nikoletou D, Miles C, MacLachlan H, et al
    High intensity exercise programme in patients with hypertrophic cardiomyopathy: a randomized trial.
    Eur Heart J. 2025;46:1803-1815.
    PubMed     Abstract available
    
    
    
94. ISHIKAWA E, Kageyama S
    Acquired von Willebrand syndrome caused by paravalvular prosthetic mitral regurgitation.
    Eur Heart J. 2025 May 13:ehaf334. doi: 10.1093.
    PubMed    
    
    
    
95. BARBANTI M, Costa G, Windecker S, Maisano F, et al
    Bicuspid aortic valve disease: advancements and challenges of transcatheter aortic valve implantation.
    Eur Heart J. 2025 May 9:ehaf307. doi: 10.1093.
    PubMed     Abstract available
    
    
    
96. PEDICINO D, Liuzzo G
    Weekly Journal Scan: does dapagliflozin expand the therapeutic options after transcatheter aortic valve implantation?
    Eur Heart J. 2025 May 6:ehaf309. doi: 10.1093.
    PubMed    
    
    
    
97. LIN S, Zhang H, Li Z
    Quadricuspid aortic valve with partial left coronary sinus isolation.
    Eur Heart J. 2025 May 2:ehaf252. doi: 10.1093.
    PubMed    
    
    
    April 2025
98. VAN KAMPEN A, Levine RA, Borger MA
    Is mitral annular disjunction the cause of arrhythmogenic mitral valve prolapse?
    Eur Heart J. 2025 Apr 24:ehaf264. doi: 10.1093.
    PubMed    
    
    
    
99. COISNE A, Lancellotti P, Cote N, Ternacle J, et al
    Blood biomarkers in left-sided valvular heart disease.
    Eur Heart J. 2025 Apr 22:ehaf232. doi: 10.1093.
    PubMed     Abstract available
    
    
    
100. LODIN K, Da Silva CO, Wang Gottlieb A, Bulatovic I, et al
     Mitral annular disjunction and mitral valve prolapse: long-term risk of ventricular arrhythmias after surgery.
     Eur Heart J. 2025 Apr 15:ehaf195. doi: 10.1093.
     PubMed     Abstract available
     
     
     
101. ZITO F, Rhellab R, de Keijzer AR
     Patient-prosthesis mismatch after aortic valve replacement: one size does not fit all.
     Eur Heart J. 2025 Apr 10:ehaf200. doi: 10.1093.
     PubMed    
     
     
     
102. PATEL KP, Baumbach A
     Clinical implications of sex-related differences in severe aortic stenosis.
     Eur Heart J. 2025 Apr 8:ehaf199. doi: 10.1093.
     PubMed    
     
     
     
103. TCHETCHE D, Pibarot P, Bax JJ, Bonaros N, et al
     Transcatheter vs. surgical aortic valve replacement in women: the RHEIA trial.
     Eur Heart J. 2025 Apr 2:ehaf133. doi: 10.1093.
     PubMed     Abstract available
     
     
     March 2025
104. LONG A, Finer J, Hartman H, Hartzel D, et al
     Deep learning for echocardiographic assessment and risk stratification of aortic, mitral, and tricuspid regurgitation: the DELINEATE-Regurgitation study.
     Eur Heart J. 2025 Mar 29:ehaf248. doi: 10.1093.
     PubMed     Abstract available
     
     
     
105. CHEN M, Michel J, Kasel AM
     26 mm SAPIEN fractured 23 mm SAPIEN and surgical prosthesis: a transcatheter aortic valve-in-valve-in-valve implantation.
     Eur Heart J. 2025 Mar 29:ehaf173. doi: 10.1093.
     PubMed    
     
     
     
106. INDOLFI C, Esposito G, Luscher TF
     TAVI or TAVR: it is time to use a single standardized acronym for percutaneous aortic valve implantation.
     Eur Heart J. 2025 Mar 13:ehaf048. doi: 10.1093.
     PubMed    
     
     
     February 2025
107. MOCUMBI A
     European Society of Cardiology guidelines for the management of valvular heart disease: should we apply these to rheumatic heart disease?
     Eur Heart J. 2025 Feb 28:ehae641. doi: 10.1093.
     PubMed    
     
     
     
108. UNGER P, Galloo X, Pibarot P
     Mixed valvular heart disease: diagnosis and management.
     Eur Heart J. 2025 Feb 27:ehaf116. doi: 10.1093.
     PubMed     Abstract available
     
     
     
109. BAUMGARTNER H, Iung B, Messika-Zeitoun D
     The Year in Cardiovascular Medicine 2024: the top 10 papers in valvular heart disease.
     Eur Heart J. 2025 Feb 27:ehaf071. doi: 10.1093.
     PubMed    
     
     
     
110. PEDICINO D, Vergallo R
     Weekly Journal Scan: is transcatheter replacement therapy for tricuspid regurgitation ready for prime time?
     Eur Heart J. 2025 Feb 19:ehaf060. doi: 10.1093.
     PubMed    
     
     
     
111. SPRINGHETTI P, Abdoun K, Dumont E, Dagenais F, et al
     Sex-related differences in prosthesis-patient mismatch after surgical aortic valve replacement and long-term outcomes.
     Eur Heart J. 2025 Feb 18:ehaf076. doi: 10.1093.
     PubMed     Abstract available
     
     
     
112. DE PAULIS R, Chirichilli I, de Kerchove L, Della Corte A, et al
     Current status of aortic valve repair surgery.
     Eur Heart J. 2025 Feb 14:ehaf038. doi: 10.1093.
     PubMed     Abstract available
     
     
     
113. VERGALLO R, Pedicino D
     Weekly Journal Scan: transcatheter vs. surgical treatment of combined severe aortic valve stenosis and obstructive coronary artery disease.
     Eur Heart J. 2025 Feb 14:ehaf023. doi: 10.1093.
     PubMed    
     
     
     
114. CREA F
     Focus on aortic stenosis prevention and mitral regurgitation diagnosis.
     Eur Heart J. 2025;46:595-597.
     PubMed    
     
     
     
115. ABDELHAMID M, Abdel Meged AM, Prendergast B, Calvo-Iglesias FE, et al
     Baseline characteristics and outcomes of rheumatic mitral valve disease: the EURObservational Research Programme Valvular Heart Disease II Survey.
     Eur Heart J. 2025 Feb 11:ehaf050. doi: 10.1093.
     PubMed     Abstract available
     
     
     
116. ANGELLOTTI D, Praz F, Windecker S
     Tricuspid and mitral regurgitation after mitral transcatheter edge-to-edge repair: a complex interplay.
     Eur Heart J. 2025 Feb 10:ehaf044. doi: 10.1093.
     PubMed    
     
     
     January 2025
117. MATSUMOTO S, Ohno Y, Noda S, Miyamoto J, et al
     Tricuspid regurgitation and outcomes in mitral valve transcatheter edge-to-edge repair.
     Eur Heart J. 2025 Jan 28:ehae924. doi: 10.1093.
     PubMed     Abstract available
     
     
     
118. LURZ P, Zancanaro E, Kresoja KP
     Personalized management of tricuspid valve regurgitation.
     Eur Heart J. 2025 Jan 11:ehae733. doi: 10.1093.
     PubMed    
     
     
     
119. AARTS HM, Voskuil M, Delewi R
     Coronary revascularization in randomized clinical trials comparing transcatheter and surgical aortic valve replacement: is it time to bridge the gap?
     Eur Heart J. 2025 Jan 9:ehae762. doi: 10.1093.
     PubMed    
     
     
     December 2024
120. ANG DTY, Lindsay MM
     Plugging the gap: vascular access closure after transfemoral transcatheter aortic valve implantation.
     Eur Heart J. 2024 Dec 23:ehae876. doi: 10.1093.
     PubMed    
     
     
     
121. GARCIA-PAVIA P, Oreziak A, Masri A, Barriales-Villa R, et al
     Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy.
     Eur Heart J. 2024;45:5071-5083.
     PubMed     Abstract available
     
     
     
122. VERGALLO R, Pedicino D
     Weekly Journal Scan: Pushing the boundaries of transcatheter aortic valve implantation in asymptomatic patients with severe aortic stenosis.
     Eur Heart J. 2024 Dec 11:ehae839. doi: 10.1093.
     PubMed    
     
     
     
123. SUN Y, Wang Z, Qian Y
     What's the relationship between secondary mitral regurgitation and secondary tricuspid regurgitation in atrial fibrillation patients and how to treat them?
     Eur Heart J. 2024 Dec 4:ehae815. doi: 10.1093.
     PubMed    
     
     
     
124. NASER JA, Siontis KC, Nkomo VT
     The steps towards understanding tricuspid regurgitation: one 'careful' step at a time and many more 'careful' steps needed.
     Eur Heart J. 2024 Dec 4:ehae816. doi: 10.1093.
     PubMed    
     
     
     
125. HALLE M, Wernhart S, Krane M
     Exercise in primary, secondary and tertiary prevention of aortic stenosis.
     Eur Heart J. 2024 Dec 4:ehae627. doi: 10.1093.
     PubMed    
     
     
     
126. BLASER MC, Back M, Luscher TF, Aikawa E, et al
     Calcific aortic stenosis: omics-based target discovery and therapy development.
     Eur Heart J. 2024 Dec 4:ehae829. doi: 10.1093.
     PubMed     Abstract available
     
     
     November 2024
127. GARG P, Pavon AG, Penicka M, Uretsky S, et al
     Cardiovascular magnetic resonance imaging in mitral valve disease.
     Eur Heart J. 2024 Nov 20:ehae801. doi: 10.1093.
     PubMed     Abstract available
     
     
     
128. LI Z, Xiang D, Hu K
     Thoracoscopic hypothermic fibrillatory arrest mitral valve replacement for severe mitral regurgitation in Marfan syndrome after Bentall procedure.
     Eur Heart J. 2024 Nov 12:ehae772. doi: 10.1093.
     PubMed    
     
     
     
129. VERGALLO R, Pedicino D
     Weekly Journal Scan: Should we treat obstructive coronary artery disease in patients undergoing transcatheter aortic valve implantation?
     Eur Heart J. 2024 Nov 12:ehae761. doi: 10.1093.
     PubMed    
     
     
     
130. COATS CJ, Masri A, Barriales-Villa R, Abraham TP, et al
     Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial.
     Eur Heart J. 2024;45:4464-4478.
     PubMed     Abstract available
     
     
     
131. CREA F
     Evolving therapeutic approaches to aortic stenosis, tricuspid regurgitation, hypertrophic cardiomyopathy, and acute heart failure.
     Eur Heart J. 2024;45:4451-4455.
     PubMed    
     
     
     October 2024
132. RHEUDE T, Ruge H, Altaner N, Pellegrini C, et al
     Comparison of strategies for vascular ACCESS closure after transcatheter aortic valve implantation: the ACCESS-TAVI randomized trial.
     Eur Heart J. 2024 Oct 29:ehae784. doi: 10.1093.
     PubMed     Abstract available
     
     
     
133. PEDICINO D, Vergallo R
     Weekly Journal Scan: RESHAPing potential treatment indications for functional mitral regurgitation in heart failure.
     Eur Heart J. 2024 Oct 29:ehae727. doi: 10.1093.
     PubMed    
     
     
     
134. PEDICINO D, Vergallo R
     Weekly Journal Scan: is MATTERHORN a game changer for secondary mitral regurgitation? Still climbing.
     Eur Heart J. 2024 Oct 11:ehae650. doi: 10.1093.
     PubMed    
     
     
     
135. DE CATERINA R, Ten Cate H, Pengo V
     Non-vitamin K oral anticoagulants in valvular heart disease before surgery: a tale of bridging vs. no bridging.
     Eur Heart J. 2024 Oct 8:ehae615. doi: 10.1093.
     PubMed    
     
     
     
136. LANCELLOTTI P, Go YY, Vannan MA
     Unveiling sex differences in valvular disease care and outcomes.
     Eur Heart J. 2024;45:3834-3836.
     PubMed    
     
     
     September 2024
137. TALHA KM, Metra M, Butler J
     Heart failure with preserved ejection fraction: underdiagnosed and undertreated in patients with tricuspid regurgitation.
     Eur Heart J. 2024 Sep 9:ehae544. doi: 10.1093.
     PubMed    
     
     
     
138. SCHOFER N, Blankenberg S
     Transfemoral or surgical aortic valve replacement in young low-risk patients with tricuspid and bicuspid aortic valve stenosis.
     Eur Heart J. 2024 Sep 5:ehae537. doi: 10.1093.
     PubMed    
     
     
     
139. SATO M, Yoshijima N, Yashima F
     Sinus sequestration due to transcatheter heart valve endothelialization after transcatheter aortic valve replacement.
     Eur Heart J. 2024 Sep 4:ehae606. doi: 10.1093.
     PubMed    
     
     
     
140. PRENDERGAST BD, Patterson T, Redwood S
     Acute coronary occlusion during valve-in-valve TAVI-a shortcut to successful prevention.
     Eur Heart J. 2024;45:3042-3044.
     PubMed    
     
     
     
141. ACKERMANN P, Abdel-Wahab M, Noack T
     Macroscopic findings of severe structural valve deterioration of a transcatheter aortic bioprosthesis.
     Eur Heart J. 2024;45:3092.
     PubMed    
     
     
     
142. MARTINSSON A, Jeppsson A
     Invited editorial on "Outcome of aortic valve replacement versus conservative treatment in asymptomatic patients with severe aortic stenosis - Five years follow-up of the AVATAR randomized controlled trial" by Banovic et al.
     Eur Heart J. 2024 Sep 1:ehae597. doi: 10.1093.
     PubMed    
     
     
     
143. BANOVIC M, Putnik S, Da Costa BR, Penicka M, et al
     Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis: long-term follow-up of the AVATAR trial.
     Eur Heart J. 2024 Sep 1:ehae585. doi: 10.1093.
     PubMed     Abstract available
     
     
     August 2024
144. BONAROS N, Gollmann-Tepekoylu C, Grimm M
     Tricuspid valve trilogy: between risks and timing for surgery.
     Eur Heart J. 2024 Aug 30:ehae562. doi: 10.1093.
     PubMed    
     
     
     
145. DREYFUS J, Juarez-Casso F, Sala A, Carnero-Alcazar M, et al
     Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE.
     Eur Heart J. 2024 Aug 30:ehae578. doi: 10.1093.
     PubMed     Abstract available
     
     
     
146. MASCHERBAUER J, Kammerlander A, Nitsche C, Bax J, et al
     Sex-related differences in severe native valvular heart disease: the ESC-EORP Valvular Heart Disease II survey.
     Eur Heart J. 2024 Aug 30:ehae523. doi: 10.1093.
     PubMed     Abstract available
     
     
     
147. NOTENBOOM ML, de Keijzer AR, Veen KM, Gokalp A, et al
     Sex-related differences in the clinical course of aortic root and ascending aortic aneurysms: the DisSEXion Study.
     Eur Heart J. 2024 Aug 26:ehae525. doi: 10.1093.
     PubMed     Abstract available
     
     
     
148. BAI L, Feng Y, Chen M
     A very rare complication of transcatheter aortic valve replacement.
     Eur Heart J. 2024 Aug 14:ehae316. doi: 10.1093.
     PubMed    
     
     
     
149. MACH F, Miteva K
     Window of opportunity for developing effective medical intervention for calcific aortic valve disease.
     Eur Heart J. 2024 Aug 12:ehae426. doi: 10.1093.
     PubMed    
     
     
     
150. LOPES LR, Ho CY, Elliott PM
     Genetics of hypertrophic cardiomyopathy: established and emerging implications for clinical practice.
     Eur Heart J. 2024;45:2727-2734.
     PubMed     Abstract available
     
     
     July 2024
151. WANG J, Hu P, Ma XJ
     Mechanical mitral valve obstruction: gone with the wind.
     Eur Heart J. 2024 Jul 16:ehae431. doi: 10.1093.
     PubMed    
     
     
     
152. GARCIA-VILLARREAL OA, Anselmi A, Beurtheret S
     Time is relative, also when comparing transcatheter edge-to-edge repair to mitral valve surgery.
     Eur Heart J. 2024 Jul 10:ehae383. doi: 10.1093.
     PubMed    
     
     
     
153. BERNARD A, Deharo P, Fauchier L
     Time matters when considering treatment for patients with mitral regurgitation.
     Eur Heart J. 2024 Jul 10:ehae384. doi: 10.1093.
     PubMed    
     
     
     
154. CREA F
     A new classification of iron-deficient heart failure, sex-related differences in the management of atrial fibrillation and mitral regurgitation, and an update on the genetics of Brugada syndrome.
     Eur Heart J. 2024;45:2267-2270.
     PubMed    
     
     
     
155. ARSENOS P, Tsioufis K, Gatzoulis KA
     Programmed ventricular stimulation for risk stratification in hypertrophic cardiomyopathy patients.
     Eur Heart J. 2024;45:2341-2342.
     PubMed    
     
     
     
156. HUANG Y, Wang C, Zhou T, Xie F, et al
     Lumican promotes calcific aortic valve disease through H3 histone lactylation.
     Eur Heart J. 2024 Jul 8:ehae407. doi: 10.1093.
     PubMed     Abstract available
     
     
     
157. MURARU D, Badano LP
     Impact of new-onset atrial fibrillation on the incidence of tricuspid regurgitation: a call to attention.
     Eur Heart J. 2024 Jul 8:ehae382. doi: 10.1093.
     PubMed    
     
     
     
158. JAHANYAR J, de Kerchove L, El Khoury G
     Forme fruste unicuspid aortic valves.
     Eur Heart J. 2024 Jul 3:ehae432. doi: 10.1093.
     PubMed    
     
     
     
159. THYREGOD HGH, De Backer O, Sondergaard L
     A notion of bioprosthetic aortic valve durability.
     Eur Heart J. 2024 Jul 2:ehae387. doi: 10.1093.
     PubMed    
     
     
     
160. LI Z, Cheng S, Guo B, Ding L, et al
     Wearable device-measured moderate to vigorous physical activity and risk of degenerative aortic valve stenosis.
     Eur Heart J. 2024 Jul 2:ehae406. doi: 10.1093.
     PubMed     Abstract available
     
     
     
161. BEKKI M, Tahara N, Fukumoto Y
     Primary cardiac lymphoma causing coronary artery compression and massive tricuspid regurgitation.
     Eur Heart J. 2024 Jul 2:ehae390. doi: 10.1093.
     PubMed    
     
     
     
162. DIMITRIADIS K, Pyrpyris N, Tsioufis K
     Long-term outcomes of transcatheter vs. surgical aortic valve replacement: is there still a question to be answered?
     Eur Heart J. 2024 Jul 2:ehae386. doi: 10.1093.
     PubMed    
     
     
     
163. NASER JA, Castrichini M, Ibrahim HH, Scott CG, et al
     Secondary tricuspid regurgitation: incidence, types, and outcomes in atrial fibrillation vs. sinus rhythm.
     Eur Heart J. 2024 Jul 2:ehae346. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2024
164. HAHN RT
     Sex-related differences in degenerative mitral regurgitation: a call to action.
     Eur Heart J. 2024 Jun 13:ehae360. doi: 10.1093.
     PubMed    
     
     
     
165. ZHUANG Y, Wang W, Lu F
     Simultaneous transcatheter aortic and tricuspid valve replacement via bilateral cervical approach.
     Eur Heart J. 2024 Jun 12:ehae352. doi: 10.1093.
     PubMed    
     
     
     
166. CREA F
     Optimizing the treatment of severe aortic stenosis.
     Eur Heart J. 2024;45:1861-1865.
     PubMed    
     
     
     
167. VERGALLO R, Pedicino D
     Weekly Journal Scan: transcatheter aortic valve implantation in patients with small aortic annulus.
     Eur Heart J. 2024 Jun 1:ehae308. doi: 10.1093.
     PubMed    
     
     
     May 2024
168. ELTCHANINOFF H, Durand E
     Transfemoral aortic valve implantation and concomitant CAD: the jury is out.
     Eur Heart J. 2024 May 31:ehae141. doi: 10.1093.
     PubMed    
     
     
     
169. WANG J, Chen X, Zhao S
     Detect and define ventricular arrhythmia substrates in hypertrophic cardiomyopathy.
     Eur Heart J. 2024 May 31:ehae312. doi: 10.1093.
     PubMed    
     
     
     
170. 
     Correction to: Severe aortic stenosis: secular trends of incidence and outcomes.
     Eur Heart J. 2024 May 27:ehae144. doi: 10.1093.
     PubMed    
     
     
     
171. AVIERINOS JF, Tribouilloy C, Bursi F, Grigioni F, et al
     Degenerative mitral regurgitation due to flail leaflet: sex-related differences in presentation, management, and outcomes.
     Eur Heart J. 2024 May 16:ehae265. doi: 10.1093.
     PubMed     Abstract available
     
     
     
172. DVIR D, Tchetche D, Leon MB, Genereux P, et al
     Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study.
     Eur Heart J. 2024 May 15:ehae303. doi: 10.1093.
     PubMed     Abstract available
     
     
     
173. JORGENSEN TH, Thyregod HGH, Savontaus M, Willemen Y, et al
     Transcatheter Aortic Valve Implantation in Low-Risk Tricuspid or Bicuspid Aortic Stenosis: The NOTION-2 Trial.
     Eur Heart J. 2024 May 15:ehae331. doi: 10.1093.
     PubMed     Abstract available
     
     
     
174. SABBAG A, Aabel EW, Castrini AI, Siontis KC, et al
     Mitral valve prolapse: arrhythmic risk during pregnancy and postpartum.
     Eur Heart J. 2024 May 14:ehae224. doi: 10.1093.
     PubMed     Abstract available
     
     
     
175. ZEPPENFELD K, de Riva M
     Arrhythmic risk in young women with mitral valve prolapse: keep your eyes open but don't jump at every shadow.
     Eur Heart J. 2024 May 14:ehae246. doi: 10.1093.
     PubMed    
     
     
     April 2024
176. PIBAROT P
     Transcatheter aortic valve replacement: benchmarking practices to optimize quality and outcomes.
     Eur Heart J. 2024 Apr 26:ehae174. doi: 10.1093.
     PubMed    
     
     
     
177. PIERONI M, Namdar M, Olivotto I, Desnick RJ, et al
     Anderson-Fabry disease management: role of the cardiologist.
     Eur Heart J. 2024;45:1395-1409.
     PubMed     Abstract available
     
     
     
178. KASKI JP, Norrish G, Gimeno Blanes JR, Charron P, et al
     Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry.
     Eur Heart J. 2024;45:1443-1454.
     PubMed     Abstract available
     
     
     
179. TAHARA N, Fukumoto Y, Tayama E
     Utility of vector flow mapping and [18F]fluorodeoxyglucose-positron emission tomography/computed tomography to assess left ventricular workload in obstructive hypertrophic cardiomyopathy.
     Eur Heart J. 2024;45:1488.
     PubMed    
     
     
     
180. BLEIZIFFER S
     Transcatheter vs. surgical treatment of aortc stenosis: long awaited long-term data, yet a long way to go.
     Eur Heart J. 2024;45:1125-1126.
     PubMed    
     
     
     March 2024
181. FRANK D, Durand E, Lauck S, Muir DF, et al
     A streamlined pathway for transcatheter aortic valve implantation: the BENCHMARK study.
     Eur Heart J. 2024 Mar 30:ehae147. doi: 10.1093.
     PubMed     Abstract available
     
     
     
182. 
     Correction to: Tricuspid valve disease and cardiac implantable electronic devices.
     Eur Heart J. 2024 Mar 29:ehae221. doi: 10.1093.
     PubMed    
     
     
     
183. BAKAR SN, Ong G, Fam NP
     LuX-Valve Plus transcatheter tricuspid valve replacement for massive tricuspid flail after lead extraction.
     Eur Heart J. 2024 Mar 29:ehae165. doi: 10.1093.
     PubMed    
     
     
     
184. 
     Correction to: Healthcare resource utilisation and safety outcomes in patients undergoing transcatheter mitral valve repair - A nationwide analysis.
     Eur Heart J. 2024 Mar 25:ehae168. doi: 10.1093.
     PubMed    
     
     
     
185. CREA F
     Mitral, aortic, and tricuspid valve disease: new light shed on mechanisms, risk stratification, and treatment optimization.
     Eur Heart J. 2024;45:857-860.
     PubMed    
     
     
     
186. BAX JJ, Hahn RT, Marsan NA, Baumgartner H, et al
     Great debate: symptomatic moderate aortic stenosis should undergo intervention.
     Eur Heart J. 2024 Mar 6:ehae050. doi: 10.1093.
     PubMed    
     
     
     
187. MARTINSSON A, Rasalingam R, Jeppsson A
     Stable incidence and outcomes for patients with incident aortic stenosis: how can we translate excellent trial data into improved clinical outcomes in the population?
     Eur Heart J. 2024 Mar 6:ehae078. doi: 10.1093.
     PubMed    
     
     
     
188. SUDO K, Nakamura K, Sato A
     Usefulness of endomyocardial biopsy using three-dimensional delivery system for the diagnosis of cardiac amyloidosis with complete atrioventricular block after transcatheter aortic valve implantation.
     Eur Heart J. 2024 Mar 5:ehae137. doi: 10.1093.
     PubMed    
     
     
     
189. MURARU D, Badano LP, Hahn RT, Lang RM, et al
     Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis, and treatment.
     Eur Heart J. 2024 Mar 5:ehae088. doi: 10.1093.
     PubMed     Abstract available
     
     
     
190. MEHILLI J
     Shortening in-hospital stay after transcatheter aortic valve implantation: a deja vu in percutaneous interventions.
     Eur Heart J. 2024 Mar 4:ehae096. doi: 10.1093.
     PubMed    
     
     
     
191. DURAND E, Beziau-Gasnier D, Michel M, Iung B, et al
     Reducing length of stay after transfemoral transcatheter aortic valve implantation: the FAST-TAVI II trial.
     Eur Heart J. 2024 Mar 4:ehae081. doi: 10.1093.
     PubMed     Abstract available
     
     
     
192. MCGREGOR M, Bews H, Jassal DS
     Thrombosis of a mechanical aortic valve: stuck between a clot and a hard place.
     Eur Heart J. 2024 Mar 4:ehae115. doi: 10.1093.
     PubMed    
     
     
     
193. MAISANO F, Hahn R, Sorajja P, Praz F, et al
     Transcatheter treatment of the tricuspid valve: current status and perspectives.
     Eur Heart J. 2024 Mar 1:ehae082. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2024
194. WU J, Zafar MA, Elefteriades JA
     Decision-making in aortic disease.
     Eur Heart J. 2024;45:633-634.
     PubMed    
     
     
     
195. MESSIKA-ZEITOUN D, Iung B, Baumgartner H
     The year in cardiovascular medicine 2023: the top 10 papers in valvular heart disease.
     Eur Heart J. 2024 Feb 21:ehae090. doi: 10.1093.
     PubMed    
     
     
     
196. LURZ P, Kresoja KP
     Surgical or percutaneous treatment of mitral regurgitation: clip or cut?
     Eur Heart J. 2024 Feb 21:ehae084. doi: 10.1093.
     PubMed    
     
     
     
197. LUDWIG S, Granada JF
     Transcatheter mitral valve replacement at an inflection point: lessons learned and the path forward.
     Eur Heart J. 2024 Feb 8:ehae013. doi: 10.1093.
     PubMed    
     
     
     
198. THYREGOD HGH, Jorgensen TH, Ihlemann N, Steinbruchel DA, et al
     Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
     Eur Heart J. 2024 Feb 7:ehae043. doi: 10.1093.
     PubMed     Abstract available
     
     
     
199. CREA F
     The dark side of arrhythmia treatment: iatrogenic tricuspid regurgitation and drug toxicity.
     Eur Heart J. 2024;45:317-320.
     PubMed    
     
     
     January 2024
200. THORNTON GD, Vassiliou VS, Musa TA, Aziminia N, et al
     Myocardial Scar and Remodelling Predict Long-Term Mortality in Severe Aortic Stenosis Beyond 10 Years.
     Eur Heart J. 2024 Jan 25:ehae067. doi: 10.1093.
     PubMed    
     
     
     
201. PERSITS I, Layoun H, Kondoleon NP, Spilias N, et al
     Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement.
     Eur Heart J. 2024 Jan 25:ehae019. doi: 10.1093.
     PubMed     Abstract available
     
     
     
202. DEHARO P, Obadia JF, Guerin P, Cuisset T, et al
     Mitral transcatheter edge to edge repair versus isolated mitral surgery for severe mitral regurgitation: A French nationwide study.
     Eur Heart J. 2024 Jan 19:ehae046. doi: 10.1093.
     PubMed     Abstract available
     
     
     
203. HAUSLEITER J, Lachmann M, Stolz L, Bedogni F, et al
     Artificial intelligence-derived risk score for mortality in secondary mitral regurgitation treated by transcatheter edge-to-edge repair: the EuroSMR risk score.
     Eur Heart J. 2024 Jan 19:ehad871. doi: 10.1093.
     PubMed     Abstract available
     
     
     
204. NAKAMURA K, Taniguchi T, Furukawa Y
     Haemolytic anaemia after transcatheter aortic valve replacement.
     Eur Heart J. 2024 Jan 18:ehae010. doi: 10.1093.
     PubMed    
     
     
     
205. LI Z, Zhang H, Lin S
     Functionally bicuspid aortic valve leads to myocardial ischaemia.
     Eur Heart J. 2024 Jan 18:ehad891. doi: 10.1093.
     PubMed    
     
     
     
206. LONG X, Deng S, Liu W, Bu J, et al
     Transcoronary radiofrequency ablation for obstructive hypertrophic cardiomyopathy: a feasibility study.
     Eur Heart J. 2024;45:233-235.
     PubMed    
     
     
     
207. HASCOET S, Bentham JR, Giugno L, Betrian-Blasco P, et al
     Outcomes of transcatheter pulmonary SAPIEN 3 valve implantation: an international registry.
     Eur Heart J. 2024;45:198-210.
     PubMed     Abstract available
     
     
     
208. BENFARI G, Essayagh B, Michelena HI, Ye Z, et al
     Severe aortic stenosis: secular trends of incidence and outcomes.
     Eur Heart J. 2024 Jan 8:ehad887. doi: 10.1093.
     PubMed     Abstract available
     
     
     
209. KADDOURA R, Al-Hijji M
     The evolution of transcatheter valvular interventions: current evidence.
     Eur Heart J. 2024;45:10-14.
     PubMed    
     
     
     December 2023
210. ALLOUBA M, Walsh R, Afify A, Hosny M, et al
     Ethnicity, consanguinity, and genetic architecture of hypertrophic cardiomyopathy.
     Eur Heart J. 2023;44:5146-5158.
     PubMed     Abstract available
     
     
     
211. INGLES J, MacArthur DG
     The moral and practical urgency of increasing diversity in genomics.
     Eur Heart J. 2023;44:5157-5159.
     PubMed    
     
     
     
212. ANDREAS M, Burri H, Praz F, Soliman O, et al
     Tricuspid valve disease and cardiac implantable electronic devices.
     Eur Heart J. 2023 Dec 14:ehad783. doi: 10.1093.
     PubMed     Abstract available
     
     
     
213. PIRIOU PG, Plessis J, Guerin P
     Transcatheter aortic valve replacement in patients with cardiogenic shock: safe and effective, but the most critical patients require further investigations.
     Eur Heart J. 2023 Dec 14:ehad808. doi: 10.1093.
     PubMed    
     
     
     
214. GRANI C
     Prime time for CMR imaging of arrhythmogenic substrate in hypertrophic cardiomyopathy.
     Eur Heart J. 2023;44:4793-4795.
     PubMed    
     
     
     
215. WANG J, Yang S, Ma X, Zhao K, et al
     Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines.
     Eur Heart J. 2023;44:4781-4792.
     PubMed     Abstract available
     
     
     November 2023
216. VERGALLO R, Volpe M
     Breaking down barriers to transcatheter aortic-valve implantation in low surgical risk patients.
     Eur Heart J. 2023 Nov 29:ehad803. doi: 10.1093.
     PubMed    
     
     
     
217. LU ZN, Yang Y, Song G
     A patient-tailored clipping strategy of transcatheter edge-to-edge repair as salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet flails.
     Eur Heart J. 2023 Nov 29:ehad802. doi: 10.1093.
     PubMed    
     
     
     
218. BRAUNWALD E, Saberi S, Abraham TP, Elliott PM, et al
     Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy.
     Eur Heart J. 2023;44:4622-4633.
     PubMed     Abstract available
     
     
     
219. TOMII D, Praz F, Windecker S
     Guideline directed medical therapy in patients with heart failure undergoing transcatheter edge-to-edge mitral valve repair: unfulfilled premise.
     Eur Heart J. 2023 Nov 15:ehad678. doi: 10.1093.
     PubMed    
     
     
     
220. CREA F
     Hot topics in valvular heart disease: tricuspid regurgitation, bicuspid aortic valve, artificial intelligence for aortic stenosis, and aortic aneurysm.
     Eur Heart J. 2023;44:4493-4496.
     PubMed    
     
     
     
221. PATEL KP, Baumbach A
     Timing treatment for tricuspid regurgitation.
     Eur Heart J. 2023 Nov 9:ehad768. doi: 10.1093.
     PubMed    
     
     
     
222. WERT L, Falk V, Potapov EV
     Severe aortic regurgitation after short-term treatment with microaxial left ventricular assist device in the transaxillary approach.
     Eur Heart J. 2023 Nov 9:ehad750. doi: 10.1093.
     PubMed    
     
     
     
223. IDHREES M, Kumar A, Velayudhan B
     'Paravalvular leak' after Bentall's procedure, yet not a paravalvular leak.
     Eur Heart J. 2023;44:4392.
     PubMed    
     
     
     
224. KODALI S, Hahn RT, Makkar R, Makar M, et al
     Transfemoral tricuspid valve replacement and one-year outcomes: the TRISCEND study.
     Eur Heart J. 2023 Nov 1:ehad667. doi: 10.1093.
     PubMed     Abstract available
     
     
     October 2023
225. HARARI E, Landes U
     Post-Transcatheter Aortic Valve Implantation paravalvular leak: multiple aetiologies and no panacea.
     Eur Heart J. 2023 Oct 28:ehad696. doi: 10.1093.
     PubMed    
     
     
     
226. KALINCZUK L, Skotarczak W, Sondergaard L, Mintz GS, et al
     Intravascular ultrasound for actual bioprosthetic heart valve expansion during transcatheter bicuspid aortic valve replacement.
     Eur Heart J. 2023 Oct 20:ehad683. doi: 10.1093.
     PubMed    
     
     
     
227. DE BACKER J, Prakash SK
     Refining the course: long-term outcome in patients with bicuspid aortic valve.
     Eur Heart J. 2023 Oct 4:ehad621. doi: 10.1093.
     PubMed    
     
     
     
228. FARJAT-PASOS JI, Dumont E, Paradis JM
     Optimizing transcatheter mitral valve replacement with direct, continuous transvalvular haemodynamic evaluation: first-in-man.
     Eur Heart J. 2023 Oct 4:ehad603. doi: 10.1093.
     PubMed    
     
     
     
229. HAHN RT, Lawlor MK, Davidson CJ, Badhwar V, et al
     Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints.
     Eur Heart J. 2023 Oct 4:ehad653. doi: 10.1093.
     PubMed     Abstract available
     
     
     
230. WEISSLER-SNIR A, Rakowski H, Meyer M
     Beta-blockers in non-obstructive hypertrophic cardiomyopathy: time to ease the heart rate restriction?
     Eur Heart J. 2023;44:3655-3657.
     PubMed    
     
     
     
231. DEVRIES JH, Irs A, Hillege HL
     The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients.
     Eur Heart J. 2023;44:3492-3494.
     PubMed    
     
     
     September 2023
232. CHHABRA ST, Takkar A, Arya RC
     An Indian female cardiologist's journey from 'TAWA' to 'TAVI-transcatheter aortic valve implantation'.
     Eur Heart J. 2023 Sep 29:ehad652. doi: 10.1093.
     PubMed    
     
     
     
233. BEYGUI F, Guillemot V, Saloux E
     Complex mitral para-prosthetic leak closure as a bridge to heart transplant.
     Eur Heart J. 2023 Sep 28:ehad602. doi: 10.1093.
     PubMed    
     
     
     
234. MOORE JP, Aboulhosn JA, Khairy P
     Electrophysiology testing before transcatheter pulmonary valve replacement in patients with repaired tetralogy of Fallot.
     Eur Heart J. 2023;44:3228-3230.
     PubMed    
     
     
     
235. CREA F
     TAVI or non-TAVI in asymptomatic aortic stenosis, in cardiogenic shock, and in patients with Heyde syndrome?
     Eur Heart J. 2023;44:3105-3109.
     PubMed    
     
     
     
236. FENG S, Wu F, Pan X
     Computational fluid dynamics as a novel method to predict haemodynamic changes and guide transcatheter edge-to-edge repair.
     Eur Heart J. 2023;44:3199.
     PubMed    
     
     
     August 2023
237. VARSHNEY AS, Shah M, Vemulapalli S, Kosinski A, et al
     Heart Failure Medical Therapy Prior to Mitral Transcatheter Edge-to-Edge Repair: The STS/ACC Transcatheter Valve Therapy Registry.
     Eur Heart J. 2023 Aug 26:ehad584. doi: 10.1093.
     PubMed     Abstract available
     
     
     
238. DREYFUS J, Galloo X, Taramasso M, Heitzinger G, et al
     TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation.
     Eur Heart J. 2023 Aug 25:ehad585. doi: 10.1093.
     PubMed     Abstract available
     
     
     
239. YANG LT, Ye Z, Wajih Ullah M, Maleszewski JJ, et al
     Bicuspid aortic valve: long-term morbidity and mortality.
     Eur Heart J. 2023 Aug 23:ehad477. doi: 10.1093.
     PubMed     Abstract available
     
     
     
240. HOLSTE G, Oikonomou EK, Mortazavi BJ, Coppi A, et al
     Severe aortic stenosis detection by deep learning applied to echocardiography.
     Eur Heart J. 2023 Aug 23:ehad456. doi: 10.1093.
     PubMed     Abstract available
     
     
     
241. VAN DISSEL AC, Opotowsky AR, Burchill LJ, Aboulhosn J, et al
     End-stage heart failure in congenitally corrected transposition of the great arteries: a multicentre study.
     Eur Heart J. 2023 Aug 18:ehad511. doi: 10.1093.
     PubMed     Abstract available
     
     
     
242. PRENDERGAST BD, Patterson T, Redwood S
     Transcatheter aortic valve implantation in patients with severe aortic stenosis and cardiogenic shock: an important step forward.
     Eur Heart J. 2023 Aug 10:ehad471. doi: 10.1093.
     PubMed    
     
     
     
243. ESSAYAGH B, Sabbag A, El-Am E, Cavalcante JL, et al
     Arrhythmic mitral valve prolapse and mitral annular disjunction: pathophysiology, risk stratification, and management.
     Eur Heart J. 2023 Aug 10:ehad491. doi: 10.1093.
     PubMed     Abstract available
     
     
     
244. AL ZAIDI M, Nickenig G, Zimmer S
     Emergency transcatheter aortic valve replacement in a 35-year-old patient with unicuspid aortic valve disease and cardiogenic shock.
     Eur Heart J. 2023 Aug 2:ehad465. doi: 10.1093.
     PubMed    
     
     
     
245. EIROS R, Gallego-Delgado M, Villacorta E
     Unravelling an hypertrophic myocardiopathy.
     Eur Heart J. 2023;44:2788.
     PubMed    
     
     
     July 2023
246. IUNG B, Pierard L, Magne J, Messika-Zeitoun D, et al
     Great debate: all patients with asymptomatic severe aortic stenosis need valve replacement.
     Eur Heart J. 2023 Jul 28:ehad355. doi: 10.1093.
     PubMed    
     
     
     
247. WALDSCHMIDT L, Seiffert M
     Heyde syndrome: treat aortic valve disease to stop gastrointestinal bleeding?
     Eur Heart J. 2023 Jul 5:ehad277. doi: 10.1093.
     PubMed    
     
     
     
248. GOLTSTEIN LCMJ, Rooijakkers MJP, Hoeks M, Li WWL, et al
     Effectiveness of aortic valve replacement in Heyde syndrome: a meta-analysis.
     Eur Heart J. 2023 Jul 5:ehad340. doi: 10.1093.
     PubMed     Abstract available
     
     
     
249. LORENZATTI D, Pina P, Slipczuk L
     Cardiovascular computed tomography in the evaluation of post-TAVI prosthesis dysfunction: the thin line between hypo attenuated leaflet thickening and clinical valve thrombosis.
     Eur Heart J. 2023;44:2350.
     PubMed    
     
     
     June 2023
250. NOTENBOOM ML, Schuermans A, Etnel JRG, Veen KM, et al
     Paediatric aortic valve replacement: a meta-analysis and microsimulation study.
     Eur Heart J. 2023 Jun 27:ehad370. doi: 10.1093.
     PubMed     Abstract available
     
     
     
251. GOEL K, Shah P, Jones BM, Korngold E, et al
     Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock.
     Eur Heart J. 2023 Jun 23:ehad387. doi: 10.1093.
     PubMed     Abstract available
     
     
     
252. 
     Corrigendum to: MitraClip single-leaflet detachment and consequent migration in atrial functional mitral regurgitation.
     Eur Heart J. 2023 Jun 21:ehad407. doi: 10.1093.
     PubMed    
     
     
     
253. TAKANO R, Tsuji A, Ogo T
     A beaded ductus arteriosus aneurysm in tetralogy of Fallot with pulmonary atresia after palliative surgery.
     Eur Heart J. 2023 Jun 17:ehad402. doi: 10.1093.
     PubMed    
     
     
     
254. PEDICINO D, Vergallo R
     Long-lasting effects of transcatheter repair of secondary mitral regurgitation: the latest lesson from COAPT trial.
     Eur Heart J. 2023 Jun 14:ehad349. doi: 10.1093.
     PubMed    
     
     
     
255. BRAY JJH, Freer R, Pitcher A, Kharbanda R, et al
     Family screening for bicuspid aortic valve and aortic dilatation: a meta-analysis.
     Eur Heart J. 2023 Jun 8:ehad320. doi: 10.1093.
     PubMed     Abstract available
     
     
     
256. EVANGELISTA A, Michelena HI
     Family screening for bicuspid aortic valve: indicated, but easy to implement?
     Eur Heart J. 2023 Jun 8:ehad057. doi: 10.1093.
     PubMed    
     
     
     
257. CREA F
     Understanding aortic stenosis: advances in the identification of actionable pharmacological targets.
     Eur Heart J. 2023;44:1847-1850.
     PubMed    
     
     
     May 2023
258. LORENZINI M, Elliott PM
     Do apical aneurysms predict sudden cardiac death in hypertrophic cardiomyopathy?
     Eur Heart J. 2023;44:1519-1521.
     PubMed    
     
     
     
259. JUSTIN PAUL G, Anne Princy S, Anju S, Anita S, et al
     Pregnancy outcomes in women with heart disease: the Madras Medical College Pregnancy And Cardiac (M-PAC) Registry from India.
     Eur Heart J. 2023;44:1530-1540.
     PubMed     Abstract available
     
     
     April 2023
260. BUTCHER SC, Essayagh B, Enriquez-Sarano M
     Rescue surgery for degenerative mitral regurgitation should be recognized for what it is: indispensable but imperfect.
     Eur Heart J. 2023 Apr 28:ehad242. doi: 10.1093.
     PubMed    
     
     
     
261. DANDEL M
     Degenerative mitral regurgitation: improving clinical decision-making and risk stratification before valve surgery or trans-catheter repair.
     Eur Heart J. 2023 Apr 28:ehad216. doi: 10.1093.
     PubMed    
     
     
     
262. LI Y, He Q, Xie M
     A rare case of papillary muscle rupture caused by percutaneous balloon mitral valvuloplasty.
     Eur Heart J. 2023 Apr 26:ehad254. doi: 10.1093.
     PubMed    
     
     
     
263. LEE J, Kim JS, Shim CY
     MitraClip single-leaflet detachment and consequent migration in atrial functional mitral regurgitation.
     Eur Heart J. 2023 Apr 26:ehad249. doi: 10.1093.
     PubMed    
     
     
     
264. PEDICINO D, Vergallo R
     Transcatheter repair for severe tricuspid regurgitation: are we going in the right direction?
     Eur Heart J. 2023 Apr 22:ehad219. doi: 10.1093.
     PubMed    
     
     
     
265. ORRINGER CE
     C-reactive protein in people with high lipoprotein a: a partner in crime or an innocent bystander?
     Eur Heart J. 2023;44:1461-1463.
     PubMed    
     
     
     
266. THERIAULT S, Mathieu P, Bosse Y
     The journey towards identification of actionable molecular pathways in calcific aortic valve stenosis.
     Eur Heart J. 2023 Apr 12:ehad134. doi: 10.1093.
     PubMed    
     
     
     
267. CHEN HY, Dina C, Small AM, Shaffer CM, et al
     Dyslipidemia, inflammation, calcification, and adiposity in aortic stenosis: a genome-wide study.
     Eur Heart J. 2023 Apr 11:ehad142. doi: 10.1093.
     PubMed     Abstract available
     
     
     
268. SEQUEIRA V, Batzner A, Maack C
     Targeting mitochondria in hypertrophic cardiomyopathy.
     Eur Heart J. 2023;44:1186-1188.
     PubMed    
     
     
     
269. NOLLET EE, Duursma I, Rozenbaum A, Eggelbusch M, et al
     Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration.
     Eur Heart J. 2023;44:1170-1185.
     PubMed     Abstract available
     
     
     March 2023
270. KAGASE A, Yamamoto M, Tokuda T
     Successful bailout clipping for rare complication of anterior mitral leaflet dissection during transcatheter edge-to-edge mitral valve repair.
     Eur Heart J. 2023 Mar 29:ehad163. doi: 10.1093.
     PubMed    
     
     
     
271. XIE Z, Zhu H
     A rare case of mitral regurgitation caused by primary aldosteronism.
     Eur Heart J. 2023 Mar 29:ehad180. doi: 10.1093.
     PubMed    
     
     
     
272. CHEN YH, Chang HH, Leu HB
     Redo-transcatheter aortic valve implantation in a patient at high risk of coronary obstruction due to sinus sequestration.
     Eur Heart J. 2023 Mar 25:ehad164. doi: 10.1093.
     PubMed    
     
     
     
273. MAS-PEIRO S, Abplanalp WT, Rasper T, Berkowitsch A, et al
     Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement.
     Eur Heart J. 2023 Mar 18:ehad093. doi: 10.1093.
     PubMed     Abstract available
     
     
     
274. CHORIN E, Topilsky Y
     The synergy between tricuspid regurgitation and machine learning.
     Eur Heart J. 2023 Mar 17:ehad140. doi: 10.1093.
     PubMed    
     
     
     
275. RAO VN, Giczewska A, Chiswell K, Felker GM, et al
     Long-term outcomes of phenoclusters in severe tricuspid regurgitation.
     Eur Heart J. 2023 Mar 16:ehad133. doi: 10.1093.
     PubMed     Abstract available
     
     
     
276. MESSIKA-ZEITOUN D, Baumgartner H, Burwash IG, Vahanian A, et al
     Unmet needs in valvular heart disease.
     Eur Heart J. 2023 Mar 16:ehad121. doi: 10.1093.
     PubMed     Abstract available
     
     
     
277. CHUNG CJ, Otto CM
     Prevention and management of paravalvular regurgitation after transcatheter aortic valve implantation.
     Eur Heart J. 2023 Mar 9:ehad151. doi: 10.1093.
     PubMed    
     
     
     
278. LANDES U, Hochstadt A, Manevich L, Webb JG, et al
     Treatment of late paravalvular regurgitation after transcatheter aortic valve implantation: prognostic implications.
     Eur Heart J. 2023 Mar 8:ehad146. doi: 10.1093.
     PubMed     Abstract available
     
     
     
279. CREA F
     Spotlight on aortic stenosis and dissection: mechanisms, management, and new therapeutic targets.
     Eur Heart J. 2023;44:783-787.
     PubMed    
     
     
     
280. RODES-CABAU J, Nuche J
     Are contemporary TAVI results influenced by hospital volume?
     Eur Heart J. 2023;44:868-870.
     PubMed    
     
     
     
281. CHEN J, Yang Y, Wei L
     One-stage transcatheter aortic valve replacement and transcatheter edge-to-edge repair for aortic and mitral regurgitation.
     Eur Heart J. 2023 Mar 3:ehad094. doi: 10.1093.
     PubMed    
     
     
     
282. KEMALOGLU OZ T, Badano LP
     Can three-dimensional echocardiography change the game for the pulmonary valve?
     Eur Heart J. 2023;44:703-705.
     PubMed    
     
     
     October 2021
283. ELLIOTT P
     Sudden cardiac death in hypertrophic cardiomyopathy: time to change the narrative.
     Eur Heart J. 2021;42:3945-3947.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum